Month figures/ConferenceFormycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences 19.11.2024 / 06:30 CET/CESTThe issuer is ...
ExpansionSiegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CESTMedia ReleaseZofingen, November 19, 2024Siegfried (SIX: SFZN), a leading global Contract ...
Commercial HighlightsAppointment of Jantzen Cole as Vice President of Market Development, Extremities, to drive the Company's acceleration beyond the spine marketStrategic expansion opens new ...
WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals ...
Ipsen presents three late-breaking presentations and eight abstracts across rare cholestatic liver disease portfolio at AASLD 2024Elafibranor was granted marketing authorisation for the treatment of ...
Integrated Outpatient Facilities Struggle with Inadequate RCM Solutions, Leading to Revenue Loss in Labs, Diagnostic Imaging, Rehabilitation, Home Health and Subacute Care NASHVILLE, TN / ACCESSWIRE / ...
Advancements Enhance Efficacy in Hypha's Revolutionary Home and Commercial Production UnitsLAS VEGAS, NV / ACCESSWIRE / November 18, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional ...
Healthcare communications agency ZPB Associates has expanded its senior team by adding Dr Arvind Madan and Dr Jenny Shand as new Senior Associates. The appointments are expected to strengthen ZPB’s ...
KANSAS CITY, KS / ACCESSWIRE / November 18, 2024 / Glow Sauna Studios, a recognized leader in holistic wellness, is pleased to announce a new multi-unit agreement, in Metro Kansas City, with the first ...
BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence software, designed to ...
ABPI has today (Monday) welcomed a new report from The King’s Fund which explores the positive impacts of NHS and industry partnerships.
MELBOURNE, AUSTRALIA / ACCESSWIRE / November 18, 2024 / Immuron Limited (NASDAQ:IMRN) has one commercial product and two pipeline assets in three clinical programs for the treatment of gut mediated ...